The effect of Vit-D on adiponectin plasma levels and insulin resistance in first-degree relatives of diabetic patients

Phase 2

• Conditions: First degree Relatives of Diabetic Patients.; Diabetes mellitus; E10, E11,

• Registration Number: IRCT201105176430N1
• Lead Sponsor: Shahid Sadoughi University of Medical sciences, Yazd Diabetes Research Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 64

Inclusion Criteria

First-degree relatives of diabetic patients; BMI >25kg/m2; age between 25-65 years. Exclusion criteria: Diabetic patients; who has consumed Vit-D supplementation or Metformin for past three months.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Insulin. Timepoint: Before intervention and 12 weeks after intervention. Method of measurement: Insulin Kit and the Unit is mu/lit.;Adiponectin. Timepoint: Before intervention and 12 weeks after intervention. Method of measurement: Adiponectin kit and the unit is ng/ml.

Secondary Outcome Measures

Name	Time	Method
FBS. Timepoint: 12 weeks. Method of measurement: Measurement of blood glucose by Auto analyzer method.;2hpp. Timepoint: 12 weeks. Method of measurement: Measurement of blood glucose by Auto analyzer method.;TG. Timepoint: 12 weeks. Method of measurement: Measurement of triglyceride by Auto Analyzer method.;Cholesterol. Timepoint: 12 weeks. Method of measurement: Measurement of cholestrol by Auto nalyser method.;HDL. Timepoint: 12 weeks. Method of measurement: Measurement of HDL by Auto Analyser method.;LDL. Timepoint: 12 weeks. Method of measurement: Measurement of LDL by Auto Analyser method.